REGENERON PHARMACEUTICALS, INC.
TARRYTOWN, NY
REGENERON PHARMACEUTICALS, INC. is a defense supplier facility identified by CAGE 544P9 in TARRYTOWN, NY. The contractor received $5.6B in prime obligations during FY2021–FY2022. No tracked subcontract awards were identified for that period. Observed award classifications include Drugs And Biologicals. Platform mappings cover 100.0% of observed prime obligation value and include HEALTHCARE.
Connected platforms
Percentages show share of all observed prime obligation value. 100% of prime obligation value currently has a platform mapping.
Upstream prime customers
Percentages show share of all tracked subcontract award value received.
No tracked upstream prime customer is shown.
Government customers
Percentages show share of all observed prime obligation value.
Subcontractors
Percentages show share of tracked subcontract awards issued.
No tracked downstream subcontractor is shown.
Observed capabilities
Connected NSNs
No observed NSNs are shown.
Continue exploring
Open Ask Mimir with this company and CAGE already in context.
Ask a questionContinue to the wider platform for deeper contracts, suppliers, parts and analysis.
Open platform